The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The Czech National Monitoring Centre for Drugs and Addiction (National Focal Point; NMC) cooperates with the EMCDDA as one of members of the Reitox network. Information about activities of the EMCDDA are shared on this website in the part EMCDDA News.